HealthCap

HealthCap is a Stockholm-based venture capital firm focused on investments in multi-stage life sciences companies.

Business Model:

Revenue: $0

Employees: 0-0

Rankings

Detailed HealthCap Information

Geographic Data

HealthCap headquarters map

Address: Engelbrektsplan 1

City: Stockholm

State: södermanlands län

Zip: 114 34

Country: SE

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$160M

Metrics

10,376,745Website Global Rank

1Website Monthly Traffic

Twitter Followers

Description

HealthCap is a family of multi stage venture capital funds, investing globally in life sciences, with the Odlander Fredrikson Group as their exclusive investments advisor. With committed capital exceeding € 800 million, HealthCap is one of the largest specialized provider of venture capital within life sciences Europe.

Contact Phone:

Contact Email:

Announced Date Company Transaction Money Raised
10/2014 Strongbridge Biopharma Venture Round 11M
6/2004 Jerini Series B 38M
2/2005 Jerini Venture Round 20.2M
1/2011 Nexstim Venture Round 0
11/2018 Precirix Series A 41.9M
1/2021 Aro Biotherapeutics Series A 88M
10/2008 ChemoCentryx Series E 50M
8/2005 Alba Therapeutics Series A 30M
7/2015 GenSight Biologics Series B 0
4/2014 Wilson Therapeutics Series B 40M
11/2008 Tengion Series C 0
6/2021 Doctrin Series C 0
4/2002 Dynavax Technologies Series D 0
4/2019 Fusion Pharmaceuticals Series B 0
6/2022 Ariceum Therapeutics Series A 0
5/2018 Rainier Therapeutics Series B 20M
3/2003 Sopherion Therapeutics Series A 0
9/2007 Nexstim Venture Round 10.9M
8/2003 BioStratum Venture Round 9.5M
3/2021 Carisma Therapeutics Series B 0
1/2015 Strongbridge Biopharma Venture Round 27.5M
4/2023 ADCendo Series A 0
4/2015 LTB4 Sweden Venture Round -
11/2006 Abionyx Pharma Series B 53.5M
9/2001 PTC Therapeutics Series D 0
1/2005 Biolipox Series C 41M
12/2014 Glionova Series A 5.7M
1/2004 PTC Therapeutics Series E 35M
11/2006 CoreValve Venture Round 20M
11/2018 InCarda Therapeutics Series B 42M
2/2023 Spruce Biosciences Post-IPO Equity 0
11/2005 PTC Therapeutics Private Equity Round 26.6M
12/2001 Hybrigenics Series B 11.6M
7/2005 CoreValve Series B 24M
2/2017 Fusion Pharmaceuticals Series A 0
7/2002 Direct Conversion Series B 21M
12/2017 Doctrin Venture Round 0
1/2003 Biolipox Series B 21M
7/2018 Modus Therapeutics Series A 15.8M
12/1998 OraPharma Inc. (acquired by JNJ) Venture Round 16M
7/2011 SpineVision Venture Round 0
2/2020 Spruce Biosciences Series B 88M
2/2023 Hemab Series B 0
6/2004 PTC Therapeutics Series E 0
1/2003 Orexo Series B 22.4M
10/2007 Tengion Series C 33M
10/2000 Arpida AG Series B 22.3M
6/2006 Tengion Series B 50M
7/2021 Hemab Series A 0
7/2010 Abionyx Pharma Series C 0
8/2003 Renovis Series E 45M
10/2020 Priothera Series A 0
6/2004 Nucleonics Series B 49.2M
9/2017 Fusion Pharmaceuticals Series A 0
9/2009 BeneChill Series C 13.5M
6/2010 FerroKin Biosciences Series B 12M
8/2005 Tengion Series A 39M
5/1998 Actelion Pharmaceuticals Venture Round 12M
9/2005 Algeta Series A 28.9M
9/2004 Sopherion Therapeutics Series B 47M
6/2011 Ultragenyx Pharmaceutical Series A 45M
6/2007 OxThera Venture Round 0
3/2007 CoreValve Series C 33M
8/2005 Abionyx Pharma Series A 30.5M
11/2009 FerroKin Biosciences Venture Round 15M
12/2001 Pharmion Venture Round 65M
12/2021 Oncorena Venture Round 0
10/2021 HelloBetter Series A 0
3/2010 Immune Targeting Systems Series A 13.2M
3/2022 HelloBetter Series A 0
3/2022 Precirix Series B 0
4/2021 ADCendo Series A 61.8M
5/2023 HelloBetter Series A 0
11/2018 Aprea Series C 0
9/2022 Pretzel Therapeutics Series A 0
1/2021 Carisma Therapeutics Series B 0
6/2018 Carisma Therapeutics Series A 0
9/2022 Carisma Therapeutics Series C 0
3/2017 Rainier Therapeutics Series B 30M
5/2017 Vivet Therapeutics Series A 41.2M
3/2010 Pulmonx Series C 0
10/2020 InCarda Therapeutics Series C 30M
11/2021 Elsa Seed Round 4.4M
1/2016 Rainier Therapeutics Series A 13M
11/2018 Oncorena Venture Round 1.6M
6/2017 Tisbury Pharmaceuticals Series A 32M
4/2014 Rainier Therapeutics Series A 6M
6/2000 Hybrigenics Series A 8.5M
12/2002 Renovo Series B 33M
3/2016 Aprea Series B 50.6M
7/2003 Bionaut Pharmaceuticals Series A 6.8M
6/2009 Lumavita Series A 5.5M
8/2019 Carisma Therapeutics Series A 6M
6/2011 BONESUPPORT Venture Round 18.6M
7/2005 OxThera Venture Round 21M
12/2012 Ultragenyx Pharmaceutical Series B 75M
4/2015 Idea Venture Round -
7/2000 Cytos Series B 32M
6/2017 Carisma Therapeutics Seed Round -
2/2015 Altimmune Post-IPO Equity 16M
9/2010 Cardoz Series A 17.6M
2/2005 Five Prime Therapeutics Series C 45M
10/2016 BONESUPPORT Venture Round 36.1M
6/2012 BONESUPPORT Venture Round 10M
12/2001 Gyros Series B 29.5M
7/2007 Immune Targeting Systems Series A 7.1M
9/2006 Resistentia Pharmaceuticals Series C 14M
6/2004 ChemoCentryx Series B 33M
11/2006 BONESUPPORT Venture Round 19.5M
4/2010 Oncos Therapeutics Series C 5.5M
6/2020 Doctrin Series B 8.9M
6/2022 Ariceum Therapeutics Series A 0
3/2022 Precirix Series B 0
3/2022 HelloBetter Series A 0
12/2021 Oncorena Venture Round 0
11/2021 Elsa Seed Round 0
10/2021 HelloBetter Series A 0
7/2021 Hemab Series A 0
6/2021 Doctrin Series C 0
4/2021 ADCendo Series A 0
3/2021 Carisma Therapeutics Series B 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research
CoBee's Logo
Copyright © CoBee 2022. All Rights Reserved.